08.21.24 -- Rising Allure And Critical Considerations Of Point-Of-Care Processing

Gain required knowledge related to the involved regulatory authorities and scientific technologies and disciplines: Next Generation Sequencing (NGS), Bioinformatics and Computer System Validation (CSV).

Examine the methods that hold potential for efficient gene therapy manufacturing and how achieving higher yields is crucial for making these treatments more accessible.

Because clinical applications for AAV are increasing rapidly, there is a high demand for further increasing yields as well as product quality, particularly for a higher percentage of full capsids in the final product.

Developing a robust chromatography platform for AAV8 purification and full capsid enrichment improves gene therapy product quality by addressing empty capsid removal and enhancing therapeutic efficacy.

Watch this presentation to learn how efficient project management and optimized communication are cornerstones of a successful transfer process.

Producing mRNA therapeutics requires navigating complex manufacturing challenges. A strategic partnership with an integrated CMO streamlines manufacturing processes and reduces costs.

The streamlined AAV transient transfection platform de-risks your path to IND and reduces complexity and timeline for lengthy process and analytical development.